The preventive and therapeutic impact of antiplatelet agents: Past and present

Minerva Medica

Volumn 100, Issue 2, 2009, Pages 133-136

  Gensini, G F ^a,b   Conti, A A ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Aspirin; Coronary artery disease; History of medicine; Platelet aggregation inhibitors; Stroke, prevention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

CORONARY ARTERY DISEASE; CORONARY RISK; HEART INFARCTION; HUMAN; REVIEW; STROKE; THROMBOSIS; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ASPIRIN; CORONARY ARTERY DISEASE; FEMALE; FIBRINOLYTIC AGENTS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; STROKE;

EID: 67749110093     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Conti AA, Lippi D, Gensini GF. Storia dell'aspirina: dall'empirismo all'evidenza. Decidere in Medicina 2005;2:32-33
2. Gibson PC. Aspirin in the treatment of vascular diseases. Lancet 1949;2: 1172-1174
3. Craven LL. Experiences with aspirin (Acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis. Miss Valley Med J 1953;75:38-44.
4. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971;231:232-235
5. Gensini GF, Conti AA, Lippi D. Evolution of the epidemiologic context of cardiovascular diseases: a critical historical approach. Ital Heart J 2002;3(Suppl 6);5S-8S.
6. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N et al. Heart Disease and Stroke Statistics - 2008 Update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-146.
7. The SPREAD Collaboration (Gensini GF, Ed.). SPREAD (Stroke Prevention and Educational Awareness Diffusion) Ictus cerebrale: linee guida italiane di prevenzione e trattamento. 5th ed. X anno. Milano: Pubblicazioni Catel - Hyperphar Group Spa; 2007.
8. Braunwald E. Shattuck lecture. Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997;337:1360-1369 (Pubitemid 27467771)
9. Conti AA, Galanti C, Gensini GF. Is evidence based medicine just a fashion? No doubt that it is a fashion to criticize it. A methodological comment of the Italian Centre for Evidence Based Medicine. Italian Heart Journal 2000;(Suppl 1):1192-1195
10. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-2398
11. World Health Organization. Prevention of cardiovascular diseases. Geneva: WHO; 2007.
12. Bartolucci AA, Howard G. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin. Am J Cardiol 2006;98:746-750 (Pubitemid 44301007)
13. BMJ Clinical Evidence Handbook. London: BMJ Publishing Group; 2008.
14. Gensini GF, Conti AA, Abbate R. A prospective study of aspirin use and the risk of pancreatic cancer in women. J Natl Cancer Inst 2004;96:637.